Zhang Financial LLC Sells 42 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Zhang Financial LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.3% in the 4th quarter, Holdings Channel reports. The institutional investor owned 625 shares of the healthcare conglomerate’s stock after selling 42 shares during the period. Zhang Financial LLC’s holdings in UnitedHealth Group were worth $316,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in UNH. MassMutual Private Wealth & Trust FSB grew its position in UnitedHealth Group by 2.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 50,557 shares of the healthcare conglomerate’s stock worth $25,575,000 after acquiring an additional 1,233 shares during the last quarter. Corundum Group Inc. raised its holdings in UnitedHealth Group by 51.4% during the 4th quarter. Corundum Group Inc. now owns 3,339 shares of the healthcare conglomerate’s stock valued at $1,689,000 after buying an additional 1,133 shares during the last quarter. Penn Davis Mcfarland Inc. grew its holdings in UnitedHealth Group by 21.8% in the 4th quarter. Penn Davis Mcfarland Inc. now owns 67,547 shares of the healthcare conglomerate’s stock worth $34,169,000 after acquiring an additional 12,085 shares during the last quarter. FLC Capital Advisors raised its stake in shares of UnitedHealth Group by 25.6% during the fourth quarter. FLC Capital Advisors now owns 2,155 shares of the healthcare conglomerate’s stock valued at $1,090,000 after acquiring an additional 439 shares during the last quarter. Finally, AMI Investment Management Inc. grew its stake in shares of UnitedHealth Group by 15.0% in the fourth quarter. AMI Investment Management Inc. now owns 5,819 shares of the healthcare conglomerate’s stock worth $2,944,000 after purchasing an additional 758 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently issued reports on UNH. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday. Royal Bank of Canada reduced their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. UBS Group reduced their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Two research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $510.03 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock has a market capitalization of $469.37 billion, a PE ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm’s 50 day moving average price is $549.37 and its 200-day moving average price is $563.70.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the business earned $5.83 earnings per share. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.77 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.